Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Explosive Buying, Drug Quality And Premier Li

This article was originally published in PharmAsia News

Executive Summary

Reports of Chinese tourists flocking to Japanese drug stores and buying up everything from cold remedies to Band-Aids seems to have caught the eye of Premier Li Keqiang, who in a Feb. 14 Cabinet meeting outlined a number of broad-brush policies to stimulate the pharma industry to improve quality and meet public health care needs.

Advertisement

Related Content

2016 Review: Rapid Change Defines China Regulatory Environment

Topics

Advertisement
UsernamePublicRestriction

Register